Related Experiment Video
Updated: May 29, 2026

A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation
Published on: April 2, 2012
No association between herpes simplex virus 1 and cardiac myxoma
Ulrich P Schurr1, Denis A Berdajs, Beate Bode
1Department of Cardiac Surgery, Triemli Hospital, Zürich, Switzerland. Ulrich.Schurr@triemli.stzh.ch
Insights
This study investigated the link between herpes simplex virus 1 (HSV-1) and cardiac myxoma. Researchers found no evidence of HSV-1 infection in cardiac myxoma tissues, suggesting it is not a contributing factor.
Area of Science:
- Cardiology
- Oncology
- Virology
Background:
- Cardiac myxoma is the most common primary cardiac tumor.
- Herpes simplex virus 1 (HSV-1) has been previously suggested as a potential factor in cardiac myxoma development.
- This study aimed to investigate the association between HSV-1 and cardiac myxoma.
Purpose of the Study:
- To determine if HSV-1 infection is associated with the occurrence of cardiac myxoma.
- To evaluate the role of HSV-1 in the pathogenesis of cardiac myxoma.
Main Methods:
- A cohort of 70 patients who underwent cardiac myxoma resection between 1965 and 2005 was studied.
- Tumor biopsies from 40 patients were analyzed using immunohistochemistry for HSV-1 antigens.
- Clinical data, including mortality, morbidity, and follow-up, were collected and analyzed.
Main Results:
- No positive signals for HSV-1 antigens were detected in the analyzed cardiac myxoma tissues.
- The study observed low peri-operative morbidity and mortality over a 40-year period.
- Complete surgical resection, including the septum, was confirmed as essential for preventing recurrence.
Conclusions:
- There is no evidence to support an association between HSV-1 infection and the occurrence of cardiac myxoma.
- Complete surgical resection remains the gold standard treatment for cardiac myxoma to prevent relapses.
- Long-term follow-up indicates favorable outcomes with low morbidity and mortality after surgical intervention.
Principles:
Cardiac myxoma is the most commonly diagnosed cardiac tumour. Infection of herpes simplex virus 1 (HSV1) has been postulated to be a factor for this pathologic entity. The aim of the current study was to evaluate the association between HSV 1 and myxoma occurrence.
Methods:
Between 1965 and 2005, 70 patients (36 female, mean age: 52.6 years) underwent a resection of myxoma. Selected variables such as hospital mortality and morbidity were studied. A follow-up (FU; mean FU time: 138 ± 83 months) was obtained (76% complete). Immunohistological studies with monoclonal antibodies against HSV type 1 were performed on tumour biopsies of 40 patients.
Results:
The mean age was 53 ± 16 years (range 23 to 84 years, 51% female). Of the investigated population, 31 (44%) were in New York Heart Association (NYHA) class III-IV. Mitral valve stenosis was identified in 14 patients (20%), and in 25 (36%) patients mitral valve was insufficient. During hospitalisation 3 patients suffered from a transient neurological disorder, and in addition to myxoma resection 18 (25.7%) patients had to undergo an additional intervention. The overall survival rate was 91% at 40 years. There was no early postoperative mortality in follow-up, although 4 patients died and 2 patients had been re-operated on for recurrent myxomas after 2 and 9 years. Immunohistology revealed no positive signals for HSV-1 antigens among the 40 analysed cases.
Conclusion:
Complete surgical resection, septum included, was the treatment of choice and mandatory to prevent relapse. Peri-operative morbidity and mortality over 40 years remained low, and no association between HSV infection and occurrence of cardiac myxoma was found.
Related Concept Videos
Herpes
Myocarditis I: Introduction
Myocarditis III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Genital Herpes
Myocarditis II: Clinical Features and Diagnostic Tests

